Currently not available for sale in Canada or the EU.
This control is formulated for use with in vitro diagnostic test methods that detect West Nile Virus (WNV) RNA in human plasma from blood donors. ACCURUN 365 Series 200 is prepared by diluting a cultured stock of intact WNV, Lineage 1 (WNV-NY2001-6263) in WNV RNA negative defibrinated human plasma. For in vitro diagnostic use.
As part of a series, this control is formulated at a specific concentration or may be used on a specific platform. Refer to the Product Insert below for more information.